Avivagen Inc. (VIVXF) Financials

VIVXF Assets vs Liabilities
DateAssetsLiabilities
July 31, 2023 205639 7.2 million
April 30, 2023 237757 6.3 million
Jan. 31, 2023 423570 5.7 million
Oct. 31, 2022 1.0 million 5.4 million

VIVXF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
July 31, 2023 53961 6523
April 30, 2023 42039 12267
Jan. 31, 2023 -97134 20740
Oct. 31, 2022 -537936 31926

VIVXF Net Income

No data available :(

VIVXF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
July 31, 2023 12965 831694 -
April 30, 2023 12586 976617 -
Jan. 31, 2023 19884 4.0 million 4033
Oct. 31, 2022 213361 3.9 million 17974

VIVXF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
July 31, 2023 58.6 million
April 30, 2023 56.7 million
Jan. 31, 2023 57.5 million
Oct. 31, 2022 56.7 million

VIVXF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
July 31, 2023 - - 325801 325801
April 30, 2023 - - 584895 -
Jan. 31, 2023 - - 242451 -
Oct. 31, 2022 - - -1.6 million -

VIVXF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
July 31, 2023 30578 12625
April 30, 2023 56884 38728
Jan. 31, 2023 49220 26294
Oct. 31, 2022 390035 223993

VIVXF

Price: $0

52 week price:
0.00
0.00

Earnings Per Share: -0.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 7769

Links: